Our Mission
We catalyze and accelerate innovation in cancer data science, thus advancing cancer research and transforming cancer prevention and care.
We seek to increase capacity for data-driven cancer research and evidence-based cancer care, by creating a hub for Penn and CHOP data scientists who work in the field. READ MORE
Announcements/News
September 2022
September 2022: The Pre-medical Cancer Immunotherapy Network for Canine Trials (PRECINCT) renewed for another five years
September 2022
September 2022: The new Biomedical Data Science Seminar Series is launched
September 2022
July 2022: SEAS/PSOM Call for Proposals for Seed Funding in Trustworthy AI for Medicine
September 2022
April 2022: SEAS/PSOM Workshop Series on Trustworthy AI for Medicine
January 2022
New in JNCI: Pandemic not associated with treatment initiation delays for patients with advanced cancer
November 2021
Workshop on Trustworthy AI for Medicine
November 2021
New at NeurIPS 2021: Assessing Fairness in the Presence of Missing Data
November 2021
New in JAMA: Some Cancer Patients More Likely to Receive Immunotherapy, Despite Lack of Benefits
October 2021
New in PNAS: Minority collapse in deep learning, unfairness for minority groups in high-stakes decisionmaking
October 2021
Rebecca Hubbard Receives Jane M. Glick Graduate Student Teaching Award
September 2021
Rebecca Hubbard Appointed Statistical Editor at NEJM